Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4Sarcoma 1

Conditions

Sarcoma 37Rhabdomyosarcoma 25Sarcoma, Ewing 18Dendritic Cell Sarcoma, Interdigitating 17Lymphoma 13Neuroectodermal Tumors, Primitive, Peripheral 10Lymphoma, Large B-Cell, Diffuse 10Neuroblastoma 8Malignant mesenchymal tumor 8HIV Infections 8Sarcoma, Kaposi 7Osteosarcoma 7Burkitt Lymphoma 7Acquired Immunodeficiency Syndrome 7Desmoplastic Small Round Cell Tumor 6Leukemia 5Wilms Tumor 4Neoplasms 4Lymphoma, Non-Hodgkin 4Central Nervous System Neoplasms 4Brain Neoplasms 4Astrocytoma 4Rhabdomyosarcoma, Embryonal 3Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Liposarcoma 3Gliosarcoma 3Glioblastoma 3Fibrosarcoma 3Bone Neoplasms 3

Interventions

Magnetic Resonance Spectroscopy 6Temozolomide 4Radiotherapy 3Cyclophosphamide 3Carmustine 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3sargramostim 2aldesleukin 2Thalidomide 2Paclitaxel 2Gadolinium DTPA 2Filgrastim 2Donepezil 2Biopsy 2temsirolimus 1surufatinib 1plerixafor 1omburtamab I-131 1ganitumab 1gallium Ga 68 dotatate 1gadobutrol 1gadobenic acid 1entinostat 1cixutumumab 1carboxyamido-triazole 1azurin (50-77) 1antineoplaston AS 2-1 1antineoplaston A10 1adavosertib 1Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors, Primitive × Vincristine × Sarcoma × Clear all
NCT00001209 2008-03-04

A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
120 enrolled
Sarcoma

Sarcoma, Sarcoma, Ewing, Osteosarcoma, Neuroectodermal Tumors, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡